RG
Redmile Group Portfolio holdings
AUM
$1.03B
1-Year Est. Return
108.56%
1 Year Est. Return
+108.56%
AUM
$1.03B
AUM Growth
+$88.2M
(+9.4%)
Holding
48
Top Buys
| 1 | +$10.9M | |
| 2 | +$8.42M | |
| 3 | +$1.77M | |
| 4 |
Neurogene
NGNE
|
+$387K |
Top Sells
| 1 | +$35.1M | |
| 2 | +$17.3M | |
| 3 | +$15.5M | |
| 4 |
Prime Medicine
PRME
|
+$11M |
| 5 |
Biohaven
BHVN
|
+$10.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Scholar Rock
SRRK
$4.49B
| $145M | 14.15% |
3,904,456
-24,583
|
|
||
2
Krystal Biotech
KRYS
$6.32B
| $117M | 11.36% |
661,388
-2,083
|
|
||
3
Stoke Therapeutics
STOK
$1.77B
| $98.1M | 9.55% |
4,175,542
-200,389
|
|
||
4
Zymeworks
ZYME
$2.01B
| $63.3M | 6.16% |
3,705,750
-444,877
|
|
||
5
ADC Therapeutics
ADCT
$533M
| $62.7M | 6.1% |
15,666,731
|
|
||
6
Immunome
IMNM
$1.69B
| $58.8M | 5.72% |
5,023,385
+151,160
|
|
||
7
LivaNova
LIVN
$3.48B
| $48.5M | 4.72% |
926,799
-7,472
|
|
||
8
Regenxbio
RGNX
$678M
| $45.3M | 4.41% |
4,693,389
-82,328
|
|
||
9
Akero Therapeutics
AKRO
$4.47B
| $35.5M | 3.45% |
747,818
-26,493
|
|
||
10
Nurix Therapeutics
NRIX
$1.79B
| $34M | 3.31% |
3,678,394
-54,494
|
|
||
11
Beam Therapeutics
BEAM
$2.57B
| $33.7M | 3.28% |
1,387,559
-35,852
|
|
||
12
Cogent Biosciences
COGT
$6.17B
| $31.7M | 3.09% |
2,209,118
+761,078
|
|
||
13
Absci
ABSI
$477M
| $25.1M | 2.44% |
8,253,316
|
|
||
|
14
Neurogene
NGNE
$327M
| $22.5M | 2.19% |
1,299,022
+22,346
|
|
||
|
ETNB
15
DELISTED
89bio
ETNB
| $21.7M | 2.11% |
1,473,136
-72,072
|
|
||
16
IDEAYA Biosciences
IDYA
$3.12B
| $20.2M | 1.96% |
742,017
+309,523
|
|
||
17
Annexon
ANNX
$671M
| $19.2M | 1.87% |
6,300,644
|
|
||
18
Fate Therapeutics
FATE
$132M
| $16.2M | 1.58% |
12,872,946
|
|
||
19
RAPT Therapeutics
RAPT
$937M
| $14.3M | 1.39% |
552,594
-78,092
|
|
||
20
Shattuck Labs
STTK
$133M
| $13.2M | 1.29% |
5,539,724
|
|
||
21
Solid Biosciences
SLDB
$423M
| $11.7M | 1.14% |
1,899,342
-16,584
|
|
||
|
SLN
22
Silence Therapeutics
SLN
$318M
| $11.2M | 1.09% |
2,164,777
|
|
||
23
Nuvation Bio
NUVB
$2.75B
| $11.2M | 1.09% |
3,031,009
|
|
||
24
Keros Therapeutics
KROS
$533M
| $8.74M | 0.85% |
552,506
|
|
||
25
Celldex Therapeutics
CLDX
$1.8B
| $8.46M | 0.82% |
327,008
-16,018
|
|